Impact of the COVID-19 Pandemic on the Use of Quaternary Ammonium Compound Disinfectants in Healthcare Facilities Within Selected States in the United States of America von Moran, Callie, Gaiko, Kathrine, Landers, Tillman, Paros, Hannah L, Xu, Chang, Fernandez, Elizabeth, Burwell, Brooke, Steve, Tyler, Margob, Sasha, Davis, Marisela, Price, Karen, Chew, Madeleine E, Worrill, Sara, Childress, Brianna R, Safford, Sara, Patel, Janvi, Marino, Jessica, Azmoodeh, Ashley, McCann, Theresa J, Hrubec, Terry

Volltext

Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes von Fischer, Melissa A, Song, Yuanbin, Arrate, Maria P, Gbyli, Rana, Villaume, Matthew T, Smith, Brianna N, Childress, Merrida A, Stricker, Thomas P, Halene, Stephanie, Savona, Michael R

Volltext

The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib von Villaume, Matthew T., Arrate, M. Pia, Ramsey, Haley E., Sunthankar, Kathryn I., Jenkins, Matthew T., Moyo, Tamara K., Smith, Brianna N., Fischer, Melissa A., Childress, Merrida A., Gorska, Agnieszka E., Ferrell, P. Brent, Savona, Michael R.

Volltext

Variable Response to BCL2 Inhibition in MDS Is Enhanced across MDS Subtypes with Synergistic Combination of BCL2+MCL1 Inhibition von Fischer, Melissa A., Arrate, Maria, Childress, Merrida A, Smith, Brianna N, Song, Yuanbin, Gbyli, Rana, Stricker, Thomas, Halene, Stephanie, Savona, Michael R.

Volltext

The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib von Villaume, Matthew T., Arrate, M. Pia, Ramsey, Haley E., Sunthankar, Kathryn I., Jenkins, Matthew T., Moyo, Tamara K., Smith, Brianna N., Fischer, Melissa A., Childress, Merrida A., Gorska, Agnieszka E., Ferrell, P. Brent, Savona, Michael R.

Volltext